Replies to post #2140 on Iterum Therapeutics (ITRM)

[exwannabe]

Good to see they got the trial launched. I had thought from their messaging it might not be till next year.

A "me too" Augmenitin is not worth much (as it is already generic). They will have to show a win in the 3rd primary for resistant bugs to get more than pocket change.

Have a ways to go here

EDIT: I would have liked to see a trial that focused on some subset of resistant bugs with endpoint of non-inferiority to doctor's choice. The space is messy though wrt to trial designs that will be allowed by the FDA (for the purpose of aprorval).

The SPA is good.